Correlation between Soluble Triggering Receptor Expressed on Myeloid Cells-1 and Endoscopic Activity in Intestinal Behçet’s Disease
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: The serum levels of soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) have recently been shown to be correlated highly with disease activity in patients with intestinal Behçet’s disease (BD). However, it remains unclearwhether sTREM-1 levels reflect endoscopic activity in intestinal BD. This study aimed to evaluate the correlation of sTREM-1 levels with endoscopic activityin intestinal BD. Materials and Methods: A total of 84 patients with intestinal BD were enrolled. Endoscopic activity was compared with sTREM-1 levels as well as other laboratory findings, including erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP). Results: sTREM-1 levels were significantly increasedin intestinal BD patients compared with controls (37.98±27.09 pg/mL vs. 16.65±7.76 pg/mL, p=0.002), however, there was no difference between endoscopicallyquiescent and active diseases (43.53±24.95 pg/mL vs. 42.22±32.68 pg/mL, p=0.819). Moreover, serum sTREM-1 levels did not differ in terms of number,shape, depth, size, margin, or type of ulcer in patients with intestinal BD. However, mean ESR and CRP levels in patients with active disease were significantlyhigher than those in patients with quiescent disease (p=0.001, p<0.001, respectively). In addition, endoscopic activity scores for intestinal BD were correlatedsignificantly with both CRP levels (γ=0.329) and ESR (γ=0.298), but not with sTREM-1 levels (γ=0.166). Conclusion: Unlike CRP levels and ESR, serum sTREM-1 levels were not correlated with endoscopic activity in patients with intestinalBD.
Abstract
Purpose: The serum levels of soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) have recently been shown to be correlated highly with disease activity in patients with intestinal Behçet’s disease (BD). However, it remains unclearwhether sTREM-1 levels reflect endoscopic activity in intestinal BD. This study aimed to evaluate the correlation of sTREM-1 levels with endoscopic activityin intestinal BD. Materials and Methods: A total of 84 patients with intestinal BD were enrolled. Endoscopic activity was compared with sTREM-1 levels as well as other laboratory findings, including erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP). Results: sTREM-1 levels were significantly increasedin intestinal BD patients compared with controls (37.98±27.09 pg/mL vs. 16.65±7.76 pg/mL, p=0.002), however, there was no difference between endoscopicallyquiescent and active diseases (43.53±24.95 pg/mL vs. 42.22±32.68 pg/mL, p=0.819). Moreover, serum sTREM-1 levels did not differ in terms of number,shape, depth, size, margin, or type of ulcer in patients with intestinal BD. However, mean ESR and CRP levels in patients with active disease were significantlyhigher than those in patients with quiescent disease (p=0.001, p<0.001, respectively). In addition, endoscopic activity scores for intestinal BD were correlatedsignificantly with both CRP levels (γ=0.329) and ESR (γ=0.298), but not with sTREM-1 levels (γ=0.166). Conclusion: Unlike CRP levels and ESR, serum sTREM-1 levels were not correlated with endoscopic activity in patients with intestinalBD.
참고문헌 (31)
- Ebert EC, "Gastrointestinal manifestations of Behçet’s disease", Dig Dis Sci, 54, pp.201~207 (2009)
- Allez M, "Role of endoscopy in predicting the disease course in inflammatory bowel disease", World J Gastroenterol, 16, pp.2626~2632 (2010)
- 천재희, "Recent Advances of Endoscopy in Inflammatory Bowel Diseases", Gut and Liver, 1(2), pp.118~125 (2007), 거트앤리버 발행위원회
- Frøslie KF, "Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort", Gastroenterology, 133, pp.412~422 (2007)
- Neurath MF, "Mucosal healing in inflammatory bowel diseases: a systematic review", Gut, 61, pp.1619~1635 (2012)
- Vermeire S, "Laboratory markers in IBD: useful, magic, or unnecessary toys?", Gut, 55, pp.426~431 (2006)
- Desai D, "Review article: biological activity markers in inflammatory bowel disease", Aliment Pharmacol Ther, 25, pp.247~255 (2007)
- Grigg EL, "Mimicry and deception in inflammatory bowel disease and intestinal behçet disease", Gastroenterol Hepatol (N Y), 8, pp.103~112 (2012)
- Cheon JH, "Development, validation, and responsiveness of a novel disease activity index for intestinal Behçet’s disease", Inflamm Bowel Dis, 17, pp.605~613 (2011)
- Lee HJ, "Correlations between endoscopic and clinical disease activity indices in intestinal Behcet’s disease", World J Gastroenterol, 18, pp.5771~5778 (2012)
- Bouchon A, "Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes", J Immunol, 164, pp.4991~4995 (2000)
- Gibot S, "Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia", N Engl J Med, 350, pp.451~458 (2004)
- Gibot S, "Surface triggering receptor expressed on myeloid cells 1 expression patterns in septic shock", Intensive Care Med, 31, pp.594~597 (2005)
- Collins CE, "Elevated synovial expression of triggering receptor expressed on myeloid cells 1 in patients with septic arthritis or rheumatoid arthritis", Ann Rheum Dis, 68, pp.1768~1774 (2009)
- Schenk M, "TREM-1--expressing intestinal macrophages crucially amplify chronic inflammation in experimental colitis and inflammatory bowel diseases", J Clin Invest, 117, pp.3097~3106 (2007)
- Tzivras M, "Role of soluble triggering receptor expressed on myeloid cells in inflammatory bowel disease", World J Gastroenterol, 12, pp.3416~3419 (2006)
- Park JJ, "Correlation of Serum-Soluble Triggering Receptor Expressed on Myeloid Cells-1 with Clinical Disease Activity in Inflammatory Bowel Disease", DIGESTIVE DISEASES AND SCIENCES, 54, pp.1525~1531 (2009), SPRINGER
- Jung YS, "Correlation between soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) expression and endoscopic activity in inflammatory bowel diseases", DIGESTIVE AND LIVER DISEASE, 44(11), pp.897~903 (2012), ELSEVIER SCIENCE INC
- Jung YS, "Expression of a soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) correlates with clinical disease activity in intestinal Behcet’s disease", Inflamm Bowel Dis, 17, pp.2130~2137 (2011)
- Cheon JH, "Development and validation of novel diagnostic criteria for intestinal Behçet’s disease in Korean patients with ileocolonic ulcers", Am J Gastroenterol, 104, pp.2492~2499 (2009)
- Solem CA, "Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease", Inflamm Bowel Dis, 11, pp.707~712 (2005)
- Jung YS, "Prognostic factors and long-term clinical outcomes for surgical patients with intestinal Behcet’s disease", Inflamm Bowel Dis, 17, pp.1594~1602 (2011)
- Choi CH, "Anti-Saccharomyces cerevisiae antibody in intestinal Behçet’s disease patients: relation to clinical course", Dis Colon Rectum, 49, pp.1849~1859 (2006)
- Saurer L, "Elevated levels of serum-soluble triggering receptor expressed on myeloid cells-1 in patients with IBD do not correlate with intestinal TREM-1 mRNA expression and endoscopic disease activity", J Crohns Colitis, 6, pp.913~923 (2012)
- Billioud V, "Plasma soluble triggering receptor expressed on myeloid cells-1 in Crohn’s disease", Dig Liver Dis, 44, pp.466~470 (2012)
- Kasahara Y, "Intestinal involvement in Behçet’s disease: review of 136 surgical cases in the Japanese literature", Dis Colon Rectum, 24, pp.103~106 (1981)
- Moon CM, "Prediction of free bowel perforation in patients with intestinal Behçet’s disease using clinical and colonoscopic findings", Dig Dis Sci, 55, pp.2904~2911 (2010)
- Ginsburg PM, "How can IBD be distinguished from IBS?", Inflamm Bowel Dis, 14(Suppl 2), pp.S152~S154 (2008)
- Grundmann O, "Irritable bowel syndrome: epidemiology, diagnosis and treatment: an update for health-care practitioners", J Gastroenterol Hepatol, 25, pp.691~699 (2010)
- Foell D, "Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease", J Pathol, 216, pp.183~192 (2008)
- 박재준, "Outcome Predictors for Intestinal Behçet’s Disease", Yonsei Medical Journal, 54(5), pp.1084~1090 (2013), 연세대학교의과대학[DOI]